Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines

Burguin, A; Furrer, D; Ouellette, G; Jacob, S; Diorio, C; Durocher, F

Durocher, F (corresponding author), Univ Laval, Ctr Rech Canc, Ctr Rech CHU Quebec, Quebec City, PQ, Canada.; Durocher, F (corresponding author), Univ Laval, Fac Med, Dept Med Mol, Quebec City, PQ, Canada.

PLOS ONE, 2020; 15 (6):

Abstract

The breast cancer (BC) biomarker HER2 (Human Epidermal Receptor 2) is overexpressed in 25% of BC. Only patients with HER2-positive tumors receive HER2......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索